Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Apr 05, 2024 1:18pm
90 Views
Post# 35973276

RE:mdjbrown...I don't understand "mystery partner named as

RE:mdjbrown...I don't understand "mystery partner named as s1i, all defendants are named in the lawsuit, however the defendant that partnered with Medipharm has not been identified to date.

The obvious choice due to national ties would be Apotex, but that has not been confirmed by Labs.

"In partnership with a large global pharmaceutical company, in Q3 MediPharm contributed API to an Abbreviated New Drug Application filed with the US Food and Drug Administration (FDA)."


ALKEM LABORATORIES LTD., Defendant
API PHARMA TECH LLC, Defendant
APOTEX INC., Defendant
ASCENT PHARMACEUTICALS, INC., Defendant
BIOPHORE PHARMA, INC., Defendant
CIPLA LTD., Defendant
CIPLA USA, INC., Defendant
Cipla (EU) Limited, Defendant
INVAGEN PHARMACEUTICALS, INC., Defendant
LUPIN LTD., Defendant
MSN LABORATORIES PRIVATE LTD., Defendant
MSN PHARMACEUTICALS, INC., Defendant
PADAGIS US LLC, Defendant
TARO PHARMACEUTICAL INDUSTRIES LTD., Defendant
TEVA PHARMACEUTICALS, INC., Defendant
ZENARA PHARMA PRIVATE LIMITED, Defendant
ZENARA PHARMA PRIVATE LTD., Defendant
<< Previous
Bullboard Posts
Next >>